Watch Insights from 2025 ISPE Pharma 4.0™ Committee Member Alicia Tébar
Katie LeChase
The 2025 ISPE Pharma 4.0™ Conference will take place from 9–10 December in Barcelona, Spain, and virtually. In the video and transcript that follows, International Program Committee Member Alicia Tébar, General Manager and Founder of QbD Pharmaceutical Services SL, highlights industry challenges the conference will help to address, exciting topics she looks forward to exploring, and what employees can learn from the conference to take back to their teams.
Many pharma teams tell me they struggle with three things.
First, data is scattered in many systems and it's really hard to see the full picture and make fast and safe decisions.
Second, compliance takes a lot of time. We must stay inspection-ready, but heavy validation can slow projects.
And third, scale up and tech transfers are risky. Moving from development to commercial often means delays, rework, and cost.
At this conference, we will share simple ways to connect data, modernize quality, and make daily work easier.
We will focus on practical new ideas:
AI and advanced analytics for continuous process verification (CPV) and faster, safer release
Digital twins to test changes before the plant and reduce scale-up risk
Model validation like computer software assurance thinking to test what really matters, automate evidence, and stay compliant
Your employer will see clear value here:
Quicker time to market with smoother transfers and fewer batch failures
Lower quality cost thanks to earlier issue detection and faster investigations
Stronger inspection readiness with clean, trustworthy digital records
And of course, Barcelona is a great place to connect—a strong pharma and biotech community, easy travel, and many partners to meet. Please join us in Barcelona for the 2025 ISPE Pharma 4.0™ Conference.
Come with your challenges and leave with concrete next steps. See you there.
Katie is a public relations and communications strategist with 15+ years of experience working hand-in-hand with organizations to develop and implement overarching communications strategies that...
As facility design, manufacturing platforms, and digital systems continue to leap forward, regulators expect quality to keep up. At the 2026 ISPE Facilities of the Future Conference, the brand-new Compliance and Quality track puts that focus front and...
Building on the discussion in Part One about the need for standardization across research and development (R&D) and quality control (QC) laboratories, this second part of the series explores how laboratories can progress toward plug-and-play automation.
Pharma companies are currently experiencing unprecedented challenges as a result of external factors such as geopolitics, the adoption of new modalities, rapidly changing technologies including digital ones, and also regulatory changes. In order to overcome these challenges, the pharmaceutical industry must accelerate and embrace new technologies, approaches and thinking. Hence to grow and...
